Orchard Therapeutics draws a lower price target at Cantor on delayed milestones
Ole Schwander/iStock via Getty Images
- Orchard Therapeutics (ORTX -2.3%
) is trading lower for the second straight session today after the company issued an update on the progress of its lead gene therapy programs. - In reaction, Cantor Fitzgerald analyst Emma…
